Patent · US Active

4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor

US9416130B2 · kind B2 · utility

1Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2015
Grant dateAug 16, 2016
Priority date—
Expiry dateMay 28, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.